Next Article in Journal
Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources
Next Article in Special Issue
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria
Previous Article in Journal
The Live Attenuated Vaccine Strain “ARRIAH” Completely Protects Goats from a Virulent Lineage IV Field Strain of Peste Des Petits Ruminants Virus
Previous Article in Special Issue
Malaria Vaccines: From the Past towards the mRNA Vaccine Era
 
 
Review

Article Versions Notes

Vaccines 2024, 12(2), 111; https://doi.org/10.3390/vaccines12020111
Action Date Notes Link
article xml file uploaded 23 January 2024 13:44 CET Original file -
article xml uploaded. 23 January 2024 13:44 CET Update https://www.mdpi.com/2076-393X/12/2/111/xml
article pdf uploaded. 23 January 2024 13:44 CET Version of Record https://www.mdpi.com/2076-393X/12/2/111/pdf
article html file updated 23 January 2024 13:46 CET Original file https://www.mdpi.com/2076-393X/12/2/111/html
Back to TopTop